← Back to Clinical Trials
Recruiting NCT07201974

NCT07201974 Virtual Reality for Post-Stroke Gait Rehabilitation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07201974
Status Recruiting
Phase
Sponsor McGill University
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2026-02-01
Primary Completion 2026-11

Trial Parameters

Condition Stroke
Sponsor McGill University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 40
Sex ALL
Min Age 40 Years
Max Age 84 Years
Start Date 2026-02-01
Completion 2026-11
Interventions
Virtual Reality Training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to: (1) implement and test the feasibility of a new VR-ODT intervention offered as part of usual therapy time of patients with a sub-acute stoke; (2) explore the acceptability of the intervention from the perspective of clinicians and patients and; (3) implement measures to optimize the uptake and sustainability of the intervention within the clinical setting. Participants will engage in a personalized VR-ODT training for 4 weeks (2X 1hr/week) targeting six well-established community walking demands related to (1) walking speed and (2) distance; (3) postural transitions; (4) obstacle avoidance; (5) dual-task walking and; (6) a combination of demands 1-5. For each demand, patients will progress through levels of increasing difficulty according to personalized goals and success criteria.

Eligibility Criteria

Inclusion Criteria: Eligible patients with stroke referred by clinicians of the inpatient and outpatient stroke rehabilitation programs at the Jewish Rehabilitation Hospital (CISSS Laval) for mobility problems over a period of 6 months will be recruited. They will: * be aged between 40 and 74 years; * have normal/corrected visual and auditory acuity present; * present a first-ever supratentorial unilateral stroke of 1-24 weeks duration; * present the ability to walk independently with/without walking aids for at least 1 min at a speed of 0.4-0.9 m/s; * present intact or mildly affected cognitive function (MoCA scores ≥ 22/30); * present intact to moderately affected visual- perceptual function (positive scores on a max. of 3/6 tasks on the Behavioural Inattention Test). Exclusion Criteria: * Subjects with comorbidities interfering with walking * Subjects with comorbidities interfering with visual perception * Subjects without medical clearance for exercise

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology